UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oklahoma is not OK: increasing accidental cannabis exposures after medical Marijuana legalization

The American journal of the medical sciences, 2024-02, Vol.367, p.S317

2024

Volltextzugriff (PDF)

529 - Oklahoma is not OK: increasing accidental cannabis exposures after medical Marijuana legalization

The American journal of the medical sciences, 2024-02, Vol.367, p.S317-S317

2024

Volltextzugriff (PDF)

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

The New England journal of medicine, 2005-10, Vol.353 (16), p.1673-1684

2005

Volltextzugriff (PDF)

Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients

Annals of oncology, 1998-03, Vol.9 (3), p.307-311

1998

Volltextzugriff (PDF)

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

Cancer, 2007-11, Vol.110 (9), p.2110-2118

2007

Volltextzugriff (PDF)

Mucormycosis of Petrous Bone in an Allogeneic Stem Cell Transplant Recipient

Clinical infectious diseases, 1998-12, Vol.27 (6), p.1546-1547

1998

Volltextzugriff (PDF)

Soluble HER2 (sHER2) levels in HER2-positive breast cancer patients receiving chemotherapy ± trastuzumab: Results from the NCCTG adjuvant trial N9831

Cancer, 2013-06, Vol.119 (15), p.2675-2682

2013

Volltextzugriff (PDF)

Do the ASCO/CAP 2007 HER2 Testing Guidelines Improve Prediction of Benefit to Adjuvant Trastuzumab?: Data from North Central Cancer Treatment Group N9831 Adjuvant Trial

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.701-701

2009

Volltextzugriff (PDF)

Autologous CD34+ cell transplantation for patients with advanced lymphoma : effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (4), p.337-343

1998

Volltextzugriff (PDF)

Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF

Journal of clinical oncology, 2000-05, Vol.18 (9), p.1824-1830

2000

Volltextzugriff (PDF)

Effect of IGF1R protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG N9831 trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10503-10503

2011

Volltextzugriff (PDF)

Effect of PTEN protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG adjuvant trial N9831

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10504-10504

2011

Volltextzugriff (PDF)

Baseline and recurrence levels of soluble HER2 (sHER2) in early-stage HER2-neu positive breast cancer (HER2+BC) from the NCCTG adjuvant Intergroup trial N9831

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.539-539

2009

Volltextzugriff (PDF)

Serum HER2 (sHER2) levels in early-stage HER2 neu (+) breast cancer (HER2+BC): Results from the NCCTG adjuvant Intergroup trial N9831

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.529-529

2008

Volltextzugriff (PDF)

A correlative study of cardiac biomarkers and left ventricular ejection fraction (LVEF) from N9831, a phase III randomized trial of chemotherapy and trastuzumab as adjuvant therapy for HER2-positive breast cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.579-579

2007

Volltextzugriff (PDF)

P2-12-02: Correlation between BMI and Clinical Outcome of Patients with Early Stage HER2+ Breast Cancer from the N9831 Clinical Trial

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-12-02

2011

Volltextzugriff (PDF)

Phase III clinical trial evaluating low-molecular weight heparin (LMWH) in patients with advanced cancer: A North Central Cancer Treatment Group study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8186-8186

2005

Volltextzugriff (PDF)

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

Supportive care in cancer, 2003-07, Vol.11 (7), p.460-464

2003

Volltextzugriff (PDF)

PD05-03: Impact of Quantitative Measurement of HER2, HER3, HER4, EGFR, ER and PTEN Protein Expression on Benefit to Adjuvant Trastuzumab in Early-Stage HER2+ Breast Cancer Patients in NCCTG N9831

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD05-03-PD05-03

2011

Volltextzugriff (PDF)

A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8001-8001

2005

Volltextzugriff (PDF)

Abstract P2-09-08: c-MYC (MYC) Protein Expression and Associations with Trastuzumab Benefit in Early-Stage, HER2+ Breast Cancer in Context of the NCCTG Adjuvant Trial, N9831

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-08

2010

Volltextzugriff (PDF)

c-MYC amplification and correlation with patient outcome in early stage HER2+ breast cancer from the NCCTG adjuvant intergroup trial N9831

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.56

2009

Volltextzugriff (PDF)

Autologous CD34 super(+) cell transplantation for patients with advanced lymphoma: Effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (4), p.337-343

1998

Volltextzugriff (PDF)

Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study

The lancet oncology, 2014-10, Vol.15 (11), p.1215-1223

2014

Volltextzugriff (PDF)

A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma

Biology of blood and marrow transplantation, 1997-10, Vol.3 (4), p.210

1997

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(88)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Oklahoma is not OK: increasing accidental cannabis exposures after medical Marijuana legalization

529 - Oklahoma is not OK: increasing accidental cannabis exposures after medical Marijuana legalization

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

Mucormycosis of Petrous Bone in an Allogeneic Stem Cell Transplant Recipient

Soluble HER2 (sHER2) levels in HER2-positive breast cancer patients receiving chemotherapy ± trastuzumab: Results from the NCCTG adjuvant trial N9831

Do the ASCO/CAP 2007 HER2 Testing Guidelines Improve Prediction of Benefit to Adjuvant Trastuzumab?: Data from North Central Cancer Treatment Group N9831 Adjuvant Trial

Autologous CD34+ cell transplantation for patients with advanced lymphoma : effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment

Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF

Effect of IGF1R protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG N9831 trial

Effect of PTEN protein expression on benefit to adjuvant trastuzumab in early-stage HER2+ breast cancer in NCCTG adjuvant trial N9831

Baseline and recurrence levels of soluble HER2 (sHER2) in early-stage HER2-neu positive breast cancer (HER2+BC) from the NCCTG adjuvant Intergroup trial N9831

Serum HER2 (sHER2) levels in early-stage HER2 neu (+) breast cancer (HER2+BC): Results from the NCCTG adjuvant Intergroup trial N9831

A correlative study of cardiac biomarkers and left ventricular ejection fraction (LVEF) from N9831, a phase III randomized trial of chemotherapy and trastuzumab as adjuvant therapy for HER2-positive breast cancer

P2-12-02: Correlation between BMI and Clinical Outcome of Patients with Early Stage HER2+ Breast Cancer from the N9831 Clinical Trial

Phase III clinical trial evaluating low-molecular weight heparin (LMWH) in patients with advanced cancer: A North Central Cancer Treatment Group study

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients

PD05-03: Impact of Quantitative Measurement of HER2, HER3, HER4, EGFR, ER and PTEN Protein Expression on Benefit to Adjuvant Trastuzumab in Early-Stage HER2+ Breast Cancer Patients in NCCTG N9831

A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study

Abstract P2-09-08: c-MYC (MYC) Protein Expression and Associations with Trastuzumab Benefit in Early-Stage, HER2+ Breast Cancer in Context of the NCCTG Adjuvant Trial, N9831

c-MYC amplification and correlation with patient outcome in early stage HER2+ breast cancer from the NCCTG adjuvant intergroup trial N9831

Autologous CD34 super(+) cell transplantation for patients with advanced lymphoma: Effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment

Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study

A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma

Suchergebnisse filtern